-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibutamoren Mesylate in Growth Hormone Deficiency
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibutamoren Mesylate in Growth Hormone Deficiency report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibutamoren Mesylate in Growth Hormone Deficiency Drug Details: Ibutamoren...
-
Product Insights
NewConforMIS Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ConforMIS Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ConforMIS Inc (ConforMIS) is a medical technology company. It manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDuo a customized bicompartmental knee replacement system. ConforMISalso provides iUni a customized unicompartmental knee replacement product, and iTotal Hip a hip replacement product...
-
Product Insights
NewJRI Orthopaedics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our JRI Orthopaedics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. JRI Orthopaedics Ltd (JRI) a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair, and reconstruction. It offers products for shoulder and knee arthoplasty, besides customized shoulder and hip products and a range of orthobiologics. Its product portfolio comprises tribofit hip system, trekking knee arthroplasty...
-
Product Insights
NewMicroPort Orthopedics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MicroPort Orthopedics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MicroPort Orthopedics Inc (MicroPort Orthopedics), a subsidiary of MicroPort Scientific Corp is medical device company that specializes in designing, manufacturing and marketing of reconstructive joint devices and related services. The company manufactures orthopedic devices for hip system, limb salvage and knee systems. Its products includes tissue sparing surgical approaches, acetabular hip system, primary and revision total knee system, and...
-
Product Insights
NewXtremity & Spinal Solutions Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Xtremity & Spinal Solutions Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Xtremity & Spinal Solutions Ltd (Xtremity & Spinal ), formerly Implants International Ltd, is a medical device company that manufactures, designs, and develops orthopedic implants, bio-engineering, and other products for the healthcare sector. The company’s products include revision systems, hip stems, hip stem ancillaries, acetabular systems, femoral heads, and acetabular poly cups, among others. It also provides...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Prostate Cancer
Overview How likely is it that the drugs in Metastatic Prostate Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Prostate Cancer Overview Metastatic prostate cancer occurs when cancerous cells...
-
Sector Analysis
Hip Reconstruction Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Hip Reconstruction Market Report Overview The hip reconstruction market size was valued at $7.90 billion in 2023. The market is forecast to grow at a CAGR of more than 3% during 2023 and 2033. Hip reconstruction or hip replacement is a procedure that involves the replacement of the damaged or diseased parts of the hip joint, especially in patients with osteoarthritis (OA) and rheumatoid arthritis (RA), as well as in cases of fractures. Hip Reconstruction Market Outlook, 2022-2033 ($ Billion)...
-
Product Insights
NewQuarterly Carbonates pricing trends in Poland
Empower your strategies with our Quarterly Carbonates pricing trends in Poland report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business choices....
-
Product Insights
NewQuarterly Energy Drinks pricing trends in Ukraine
Empower your strategies with our Quarterly Energy Drinks pricing trends in Ukraine report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Product Insights
NewLumoptik Inc. Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Lumoptik Inc. Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Lumoptik Inc is a medical device company that has developed the BrightPointTM needle guidance system to assist physicians with needle placement during epidural procedures for childbirth, spine/back pain and surgical procedures such as knee and hip replacements. The company is headquartered in Spring Grove, Illinois, the US. GlobalData's Medical Devices company profile report, “Lumoptik Inc. Pipeline Insight and Competitive Landscape,...